Fangzhou Inc. Recognized as a Leading AI Innovator in Guangzhou for Its Intelligent Healthcare Platform
Fangzhou Inc.’s Recognition in AI Healthcare Innovations
Overview of Fangzhou Inc.
Fangzhou Inc. is a prominent player in online healthcare solutions in China, focusing on managing chronic conditions. As of December 31, 2024, the company boasts an impressive count of 49.2 million registered users and 223,000 medical professionals on its platform. Specializing in customized medical care and precision medicine, Fangzhou aims to revolutionize the healthcare landscape in China and beyond.
Recent Accolades
On March 27, 2025, Fangzhou was honored with two significant awards during the "Guangzhou Artificial Intelligence Innovation Development List" announcement. The company earned the title of "Most Promising Enterprise," while its innovative H2H Smart Healthcare Ecosystem secured a place among the top 10 AI-driven healthcare applications. These awards, presented by the Guangzhou Municipal Science and Technology Bureau, underline Fangzhou’s commitment to technological excellence and its influence on the digital healthcare industry.
Dr. Xie Fangmin, the founder and CEO of Fangzhou, expressed his pride in the recognition, stating that it highlights the company’s achievements in developing effective and scalable AI solutions in healthcare. He emphasized Fangzhou’s dedication to improving healthcare efficiency and accessibility through intelligent solutions.
Strategic Collaboration with Tencent
Fangzhou has strengthened its partnership with Tencent Health and Tencent Cloud, focusing on enhancing AI-driven healthcare services. This collaboration integrates advanced open-source AI models, specifically the DeepSeek-V3 and DeepSeek-R1, into Fangzhou’s offerings. The implementation of these models is part of an ongoing effort that began in February 2025 with the local deployment of DeepSeek’s large language model. Leveraging Tencent’s robust cloud infrastructure, Fangzhou aims to upgrade its "AI Agent 2.0" platform, unlocking new transformative applications in areas like pharmaceutical logistics and overall healthcare services.
Flagship AI Modules for Enhanced Efficiency
The H2H Smart Healthcare Ecosystem features four critical AI modules designed to optimize various healthcare operations:
- AI Physician Assistant: A tool that aids healthcare professionals in diagnosing and managing patient care effectively.
- AI Customer Engagement Assistant: This module helps streamline communication with patients, improving their overall experience.
- AI Procurement Orchestrator: Focused on optimizing the supply chain, this module ensures that medical supplies are managed efficiently.
- AI Content Assistant: It assists in generating relevant content, helping educate patients and healthcare providers alike.
These modules collectively aim to enhance operational efficiency while delivering better experiences for both patients and healthcare providers.
About the Guangzhou AI Innovation Development List
Now in its third year, the "Guangzhou Artificial Intelligence Innovation Development List" recognizes leading players in the AI sector, celebrating their innovative contributions and applications. By spotlighting these enterprises, the initiative supports collaboration across Guangzhou’s AI value chain and encourages a more integrated ecosystem. This recognition not only brings visibility to the companies involved but also promotes the advancements necessary for the growth of AI technologies in healthcare and other fields.
Contact Information
For media inquiries or interviews, you can reach out to:
Xingwei Zhao
Associate Director of Public Relations
Email: [email protected]
Fangzhou Inc. continues to lead the way in integrating artificial intelligence into healthcare, paving the path for future innovations that promise to enhance the delivery of medical services and improve patient outcomes. By embracing cutting-edge technologies and strategically collaborating with industry leaders, Fangzhou is positioning itself as a key player in transforming the healthcare landscape in China and potentially across the globe.
